Hantz Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,483
| Closed | -$287K | – | 1264 |
|
|
2023
Q3 | $287K | Buy |
2,483
+717
| +41% | +$82.9K | 0.01% | 528 |
|
|
2023
Q2 | $182K | Sell |
1,766
-2,238
| -56% | -$231K | ﹤0.01% | 543 |
|
|
2023
Q1 | $437K | Sell |
4,004
-145,111
| -97% | -$15.8M | 0.01% | 481 |
|
|
2022
Q4 | $17M | Buy |
149,115
+1,712
| +1% | +$195K | 0.51% | 50 |
|
|
2022
Q3 | $9.12M | Sell |
147,403
-4,758
| -3% | -$294K | 0.32% | 95 |
|
|
2022
Q2 | $12.1M | Buy |
152,161
+2,083
| +1% | +$166K | 0.41% | 65 |
|
|
2022
Q1 | $15.8M | Buy |
150,078
+11,403
| +8% | +$1.2M | 0.47% | 50 |
|
|
2021
Q4 | $14.9M | Buy |
138,675
+10,045
| +8% | +$1.08M | 0.43% | 63 |
|
|
2021
Q3 | $14.1M | Buy |
128,630
+19,103
| +17% | +$2.09M | 0.46% | 57 |
|
|
2021
Q2 | $10.3M | Buy |
109,527
+7,434
| +7% | +$696K | 0.38% | 72 |
|
|
2021
Q1 | $9.4M | Buy |
102,093
+6,815
| +7% | +$627K | 0.39% | 67 |
|
|
2020
Q4 | $6.97M | Buy |
95,278
+2,779
| +3% | +$203K | 0.31% | 90 |
|
|
2020
Q3 | $7.19M | Buy |
92,499
+1,774
| +2% | +$138K | 0.37% | 71 |
|
|
2020
Q2 | $5.04M | Buy |
+90,725
| New | +$5.04M | 0.28% | 106 |
|